title: 100% rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory.
abstract: OBJECTIVE
  To verij5 the efficacy of the quality control (QC) program in a cytologic laboratwy with a rapid rescreening (RR) protocol.
  
  
  METHODS
  RR, according to the Turret RR method, of all samples initially screened as negative at the Laboratory of Cytology, Adolfo Lutz Institute, was performed. The slides were reviewed for 60 seconds. Suspect smears were fully checked by 2 reviewers to determine the final diagnoses. A total of 2954 sequential cytologic results were considered in this study. Of the 2954, 2568 (86.9%) were considered initially negative according to our internal QC, and these cases underwent RR. Also, 10% were randomly selected from these negative cases for full reviewing. The internal QC in our laboratory includes review of cases selected according to clinical and cytomorphologic criteria.
  
  
  RESULTS
  Among the 2954 total cases, QC detected 386 (13%) atypias with final diagnoses reported according to The Bethesda System 2001 as follows: 82 (2.18%) low grade squamous intraepithelial lesions (LSILs), 35 (1.18%) high grade squamous intraepithelial lesions (HSILs), 2 (0.06%) squamous cell carcinomas, 105 (3.5%) atypical cells of undetermined significance (ASC-US), 4 (0.12%) atypical endocervical cells (AECs) and 158 (5.3%) unsatisfactory samples. RR of 2568 smears initially considered negative selected 194 (7.5%) slides. Of the 194, 146 (75.3%) were negative, 28 (14.4%) ASC-US, 5 (2.6%) AEC, 1 (0.5%) LSIL and 14 (7.2%) unsatisfactory. Full review of a 10% random fraction of the 2568 cases interpreted as negative did not detect lesions but did detect 5 (1.95%) unsatisfactory samples.
  
  
  CONCLUSIONS
  Internal QC used in our laboratory based on clinical and cytomorphologic criteria to select cases for review proved to be an efficient method of detecting HSIL and cervical cancer. The consensus basis of this program strongly limits the false positive and false negative rates and also provides subjects with continuing education. One hundred percent RR is more efficient than 10% full reviewing in detecting cervical abnormalities.
authors.affiliation: Division of Pathology, Adolfo Lutz Institute, São Paulo, Brazil. gmattosinho@uol.com.br
authors.forename: Maria da Gloria
authors.initials: Mda G
authors.lastname: Mattosinho de Castro Ferraz
authors.forename: Miria
authors.initials: M
authors.lastname: Dall' Agnol
authors.forename: Celso
authors.initials: C
authors.lastname: di Loreto
authors.forename: Wiliam M
authors.initials: WM
authors.lastname: Pirani
authors.forename: Maria Lúcia
authors.initials: ML
authors.lastname: Utagawa
authors.forename: Sonia Maria Miranda
authors.initials: SM
authors.lastname: Pereira
authors.forename: Yuriko Ito
authors.initials: YI
authors.lastname: Sakai
authors.forename: Camilo Lelis
authors.initials: CL
authors.lastname: Feres
authors.forename: Lai W S
authors.initials: LW
authors.lastname: Shih
authors.forename: Luzia Setuko
authors.initials: LS
authors.lastname: Yamamoto
authors.forename: Rosemeire O L
authors.initials: RO
authors.lastname: Rodrigues
authors.forename: Neuza Kasumi
authors.initials: NK
authors.lastname: Shirata
authors.forename: Adhemar
authors.initials: A
authors.lastname: Longatta Filho
mesh_terms: D001938:Brazil; D003581:Cytodiagnosis / Q000592:standards*; D005260:Female; D006801:Humans; D007753:Laboratories / Q000592:standards*; D008403:Mass Screening / Q000592:standards*; D008485:Medical Audit; D015980:Public Health Practice / Q000592:standards*; D011785:Quality Assurance, Health Care / Q000379:methods*; D012680:Sensitivity and Specificity; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D014626:Vaginal Smears / Q000592:standards*